A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 74,500 shares of RXST stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,500
Previous 18,700 298.4%
Holding current value
$2.51 Million
Previous $1.13 Million 227.29%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.78 - $57.04 $3.44 Million - $4.81 Million
84,253 Added 66.09%
211,743 $10.5 Million
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $191,041 - $243,594
-3,789 Reduced 2.89%
127,490 $7.67 Million
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $815,025 - $1.33 Million
22,952 Added 21.19%
131,279 $6.77 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $2.21 Million - $4.32 Million
105,526 Added 3767.44%
108,327 $4.37 Million
Q3 2023

Nov 14, 2023

SELL
$27.05 - $33.37 $6.91 Million - $8.53 Million
-255,473 Reduced 98.92%
2,801 $78,000
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $3.46 Million - $6.1 Million
211,154 Added 448.12%
258,274 $7.44 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $486,632 - $645,232
38,683 Added 458.49%
47,120 $785,000
Q4 2022

Feb 14, 2023

SELL
$9.93 - $14.2 $153,507 - $219,517
-15,459 Reduced 64.69%
8,437 $106,000
Q3 2022

Nov 14, 2022

SELL
$11.19 - $15.85 $68,169 - $96,558
-6,092 Reduced 20.31%
23,896 $287,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $930M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.